251 related articles for article (PubMed ID: 28600778)
1. Semisynthesis and biological evaluation of prenylated resveratrol derivatives as multi-targeted agents for Alzheimer's disease.
Puksasook T; Kimura S; Tadtong S; Jiaranaikulwanitch J; Pratuangdejkul J; Kitphati W; Suwanborirux K; Saito N; Nukoolkarn V
J Nat Med; 2017 Oct; 71(4):665-682. PubMed ID: 28600778
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease.
Li SY; Wang XB; Kong LY
Eur J Med Chem; 2014 Jan; 71():36-45. PubMed ID: 24269515
[TBL] [Abstract][Full Text] [Related]
3. The resveratrol trimer miyabenol C inhibits β-secretase activity and β-amyloid generation.
Hu J; Lin T; Gao Y; Xu J; Jiang C; Wang G; Bu G; Xu H; Chen H; Zhang YW
PLoS One; 2015; 10(1):e0115973. PubMed ID: 25629409
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of centipedegrass against Aβ oligomerization and Aβ-mediated cell death in PC12 cells.
Song Y; Kim HD; Lee MK; Kim MK; Kang SN; Ko YG; Won CK; Kim GS; Lee SS; Bai HW; Chung BY; Cho JH
Pharm Biol; 2015; 53(9):1260-6. PubMed ID: 25853960
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced inflammation and oxidative stress.
Chiang MC; Nicol CJ; Cheng YC
Neurochem Int; 2018 May; 115():1-10. PubMed ID: 28989083
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol and Amyloid-Beta: Mechanistic Insights.
Jia Y; Wang N; Liu X
Nutrients; 2017 Oct; 9(10):. PubMed ID: 29036903
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Activity of
Hanafy DM; Prenzler PD; Burrows GE; Gurusinghe S; Thejer BM; Obied HK; Hill RA
Nutrients; 2020 May; 12(5):. PubMed ID: 32397683
[TBL] [Abstract][Full Text] [Related]
8. Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity.
Savaskan E; Olivieri G; Meier F; Seifritz E; Wirz-Justice A; Müller-Spahn F
Gerontology; 2003; 49(6):380-3. PubMed ID: 14624067
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease.
Iraji A; Firuzi O; Khoshneviszadeh M; Tavakkoli M; Mahdavi M; Nadri H; Edraki N; Miri R
Eur J Med Chem; 2017 Dec; 141():690-702. PubMed ID: 29107423
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of novel indandione derivatives as multifunctional agents with cholinesterase inhibition, anti-β-amyloid aggregation, antioxidant and neuroprotection properties against Alzheimer's disease.
Mishra CB; Manral A; Kumari S; Saini V; Tiwari M
Bioorg Med Chem; 2016 Aug; 24(16):3829-41. PubMed ID: 27353888
[TBL] [Abstract][Full Text] [Related]
11. 3,5,4'-trihydroxy-6,7,3'-trimethoxyflavone protects against beta amyloid-induced neurotoxicity through antioxidative activity and interference with cell signaling.
Telerman A; Ofir R; Kashman Y; Elmann A
BMC Complement Altern Med; 2017 Jun; 17(1):332. PubMed ID: 28645294
[TBL] [Abstract][Full Text] [Related]
12. Biological and computational evaluation of resveratrol inhibitors against Alzheimer's disease.
Koukoulitsa C; Villalonga-Barber C; Csonka R; Alexi X; Leonis G; Dellis D; Hamelink E; Belda O; Steele BR; Micha-Screttas M; Alexis MN; Papadopoulos MG; Mavromoustakos T
J Enzyme Inhib Med Chem; 2016; 31(1):67-77. PubMed ID: 26147348
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.
Marambaud P; Zhao H; Davies P
J Biol Chem; 2005 Nov; 280(45):37377-82. PubMed ID: 16162502
[TBL] [Abstract][Full Text] [Related]
14. Neuritogenic activity of bi-functional bis-tryptoline triazole.
Jiaranaikulwanitch J; Tadtong S; Govitrapong P; Fokin VV; Vajragupta O
Bioorg Med Chem; 2017 Feb; 25(3):1195-1201. PubMed ID: 28043778
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol, a neuroprotective supplement for Alzheimer's disease.
Li F; Gong Q; Dong H; Shi J
Curr Pharm Des; 2012; 18(1):27-33. PubMed ID: 22211686
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and evaluation of pterostilbene β-amino alcohol derivatives as multifunctional agents for Alzheimer's disease treatment.
Zheng Y; Qiang X; Xu R; Song Q; Tian C; Liu H; Li W; Tan Z; Deng Y
Bioorg Chem; 2018 Aug; 78():298-306. PubMed ID: 29625269
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of resveratrol derivatives as Aß(₁-₄₂) aggregation inhibitors, antioxidants, and neuroprotective agents.
Lu C; Guo Y; Li J; Yao M; Liao Q; Xie Z; Li X
Bioorg Med Chem Lett; 2012 Dec; 22(24):7683-7. PubMed ID: 23127891
[TBL] [Abstract][Full Text] [Related]
18. BACE1 and cholinesterase inhibitory activities of Nelumbo nucifera embryos.
Jung HA; Karki S; Kim JH; Choi JS
Arch Pharm Res; 2015 Jun; 38(6):1178-87. PubMed ID: 25300425
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of AD.
Digiacomo M; Chen Z; Wang S; Lapucci A; Macchia M; Yang X; Chu J; Han Y; Pi R; Rapposelli S
Bioorg Med Chem Lett; 2015 Feb; 25(4):807-10. PubMed ID: 25597007
[TBL] [Abstract][Full Text] [Related]
20. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
